Regulatory Spine Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery byTim AllenJuly 8, 2025
Biologics Regulatory MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants byJosh SandbergJune 20, 2024
Regulatory Spine Spineology® Announces FDA De Novo Grant of Minimally Invasive OptiMesh® Expandable Interbody Fusion System byJosh SandbergSeptember 21, 2020
